Xeris Pharmaceuticals, Inc. is an equal employment opportunity and affirmative action employer that does not discriminate on the basis of race, color, religion, sex, gender identity, sexual orientation, national origin, age, disability, veteran status, genetics or any other characteristic protected by law.
The Executive Director, Global Program Lead is responsible for leading the XP-8121 program through Phase 3 execution, regulatory approval, and a successful launch, driving the cross-functional strategy and rigorous execution, and possessing a strong commercial mentality to ensure that Clinical, CMC and Medical strategies deliver the target product profile and ultimate market access and adoption.
Xeris Pharmaceuticals, Inc. is an equal employment opportunity and affirmative action employer that does not discriminate on the basis of race, color, religion, sex, gender identity, sexual orientation, national origin, age, disability, veteran status, genetics or any other characteristic protected by law.
Xeris Biopharma Holdings, Inc.